(866) 855-6468
Log In

Log In

Forgot Your Password?

Cart Subtotal: $0.00

Latisse®/ Bimatoprost Disclaimers

Important Product and Safety Information About Latisse

Long Lashes Delivered to your door...at the lowest price, guaranteed

 

Important Product and Safety Information About Latisse® and Bimatoprost Lash Growth Treatments

Possible Side Effects

The most common side effects after using Latisse or its generic equivalent bimatoprost are an itching sensation in the eyes and/or eye redness, which were reported in approximately 4% of clinical trial patients. The solution may cause other less common side effects which typically occur close to where it is applied. These include skin darkening, eye irritation, dryness of the eyes and redness of the eyelids.

If you develop a new ocular condition (e.g., trauma or infection), experience a sudden decrease in visual acuity, have ocular surgery, or develop any ocular reactions, particularly conjunctivitis and eyelid reactions, you should immediately seek your physician’s advice concerning the continued use of Latisse or bimatoprost solution.

Special Warnings

Latisse or bimatoprost solution is intended for use on the skin of the upper eyelid margins at the base of the eyelashes. DO NOT APPLY to the lower lid. If you are using Lumigan® ophthalmic solution or other products for elevated intraocular pressure (IOP), or if you have a history of abnormal IOP, you should only use Latisse or bimatoprost under the close supervision of your physician.

Latisse bimatoprost solution use may cause darkening of the eyelid skin which may be reversible. Their use may cause increased brown iris pigmentation of the colored part of the eye which is likely to be permanent. While very infrequent, increased iris pigmentation has occurred when Latisse was administered.

It is possible for hair growth to occur in other areas of your skin that Latisse bimatoprost frequently touches. Any excess solution outside the upper eyelid margin should be blotted with a tissue or other absorbent material to reduce the chance of this happening. It is possible for a difference in eyelash length, thickness, fullness, pigmentation (darkness), number of eyelash hairs and/or direction of eyelash growth to occur between eyes (e.g., results may vary for each eye). These differences, should they occur, will usually go away if you stop using the treatment.

Important Application Tips

When applying Latisse or bimatoprost solution, it's important to follow the complete directions. Here are a few simple things to keep in mind:

  • Do not apply in the eye or to the lower lid.
  • Only use the sterile applicators supplied with Latisse or bimatoprost to apply the product.
  • Don't allow the tip of the bottle or applicator to touch fingers or any other unintended surface, as contamination by common bacteria is known to cause infections.
  • Remove contact lenses prior to application. Contact lenses may be reinserted 15 minutes afterward.
  • Remember, if you stop using the product, lashes will gradually return to their previous appearance.

To learn more, ask your doctor and see the Product Information.

Safety Information
If you use/used prescription products for eye pressure problems, use Latisse or bimatoprost under doctor care. May cause brown darkening of the colored part of the eye which is likely permanent. Latisse or bimatoprost may cause eyelid skin darkening which may be reversible. Only apply at base of upper lashes. DO NOT APPLY to lower lid. Hair may grow outside the treatment area. If you have eye problems/surgery, consult your doctor. Common side effects include itchy and red eyes. If discontinued, lashes gradually return to previous appearance. To report a side effect from Latisse, please call Allergan at 1-800-433-8871.
Approved Use
Latisse (bimatoprost ophthalmic solution) 0.03% is an FDA-approved treatment to grow eyelashes for people with inadequate or not enough lashes. Bimatoprost Ophthalmic Solution 0.03% by Sandoz is an FDA-approved generic equivalent to Latisse.

Please see Latisse full Product Information.

  • CherylLeeMD